Skip to main content

Table 10 ICERs calculated for the threatened preterm birth models using cases of CP averted as the measure of effectiveness

From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

Analysis

Method

Cost

Δ cost

Cases w/o CP

Δ cases w/o CP

ICER

Status

Health system perspective

MgSO4

$2,055

$425

0.96

0.01

$28,755

a

No MgSO4

$1,630

 

0.95

   

Societal perspective

MgSO4

$61,028

-$22,109

0.96

0.01

-$1,494,500

Dominant

 

No MgSO4

$83,137

 

0.95

   
  1. aCost-effectiveness is dependent on the willingness-to-pay threshold of the decision-maker.